Brevi-inflammin: novel actinobacterial COX-2 inhibitor for alleviating rheumatoid arthritis inflammation
- Type
- Retraction
- Notice date
- 2/14/2026 0:00
- Journal
- Naunyn-Schmiedeberg's Archives of Pharmacology
- Publisher
- Springer - Nature Publishing Group
- Notice DOI
- 10.1007/s00210-025-04654-2
- Original paper DOI
- 10.1007/s00210-025-04654-2